To further investigate the role of the DICER1 gene in breast cancer, we conducted drug sensitivity analysis and molecular docking analysis to explore the potential of DICER1 in predicting drug response and serving as a potential therapeutic target. This evidence concerns the gene DICER1 and breast cancer.